Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sentinel lymph node mapping in non-small cell lung cancer].

Tetsuaya Okunaka1, Harubumi Kato

  • 1Pulmonary Disease Center, Sanno Hospital, International University of Health and Welfare, Tokyo, Japan.

Nihon Geka Gakkai Zasshi
|November 25, 2003
PubMed
Summary

Sentinel lymph node (SLN) mapping is investigational in lung cancer but feasible. Radioisotope tracers are more accurate than dye for identifying SLNs in non-small cell lung cancer (NSCLC).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein co-expression network-based profiles revealed from laser-microdissected cancerous cells of lung squamous-cell carcinomas.

Scientific reports·2021
Same author

The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome.

Clinical and translational medicine·2021
Same author

The human melanoma proteome atlas-Defining the molecular pathology.

Clinical and translational medicine·2021
Same author

Mutant Proteomics of Lung Adenocarcinomas Harboring Different <i>EGFR</i> Mutations.

Frontiers in oncology·2020
Same author

A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis.

Scientific reports·2020
Same author

Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma.

Scientific reports·2020

Area of Science:

  • Oncology
  • Surgical Oncology
  • Nuclear Medicine

Background:

  • Sentinel lymph node (SLN) identification is standard for breast cancer and melanoma.
  • SLN mapping in non-small cell lung cancer (NSCLC) is currently investigational.
  • Accurate SLN identification is crucial for staging and treatment planning in NSCLC.

Purpose of the Study:

  • To evaluate the feasibility and accuracy of SLN mapping in NSCLC patients.
  • To compare the effectiveness of dye versus radioisotope tracers for SLN identification in lung cancer.

Main Methods:

  • SLN mapping performed in NSCLC patients.
  • Utilized both isosulfan blue dye and radioisotope tracers.
  • Pathological examination of identified SLNs using sensitive techniques.

Related Experiment Videos

Main Results:

  • SLN mapping is feasible in NSCLC patients.
  • The radioisotope method demonstrated higher accuracy compared to the dye technique.
  • SLN identification allows for focused pathological analysis, detecting metastases and skip metastases.

Conclusions:

  • SLN mapping is a viable technique for staging NSCLC.
  • Radioisotope tracers offer superior accuracy for SLN identification in lung cancer.
  • Accurate SLN identification improves the detection of nodal metastasis in NSCLC.